Marc Carrier/X
Apr 13, 2026, 12:48
Marc Carrier: The Vermont Model Demonstrates the Power of VTE Prevention
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a recent article by Chris Holmes et al, published in JCO Oncology Practice:
”Real-world evidence confirms what trials have shown: guideline-based VTE prevention matters.
In high-risk ambulatory cancer patients, a multidisciplinary program (‘Vermont model‘) led to:
- VTE: 3.2% vs 7.7% (OR 0.36)
- 6-month mortality: 16.8% vs 31.3% (OR 0.46)
- Despite strong evidence, uptake remains suboptimal, closing this gap is an immediate opportunity to improve outcomes in cancer care.”
Title: Impact of Venous Thrombosis Prevention in Ambulatory Oncology: Importance of Guideline Adherence
Authors: Chris Holmes, Karlyn Martin, Derek Devine, Jacob Barker, Peter Callas, Karen Libby, Emily Parenteau, Mary Cushman, Steven Ades
Read the Full Article on JCO Oncology Practice

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 28, 2026, 15:10Ify Osunkwo: Strengthening Sickle Cell Care Systems at Global Conference in Nairobi
-
Aug 28, 2026, 15:08Muhammed Safvan: One Drop of Blood Can Tell a Story
-
Aug 28, 2026, 14:52Jessica Lee: Standing Together for Children and Families with Bleeding Disorders
-
Aug 28, 2026, 14:45Daisy Souster: A New Chapter in Bleeding Disorder Advocacy
-
Aug 28, 2026, 14:42Oluwatoyin Iyabode Ajayi: Heavy Periods – When Is Menstrual Bleeding Too Much?
-
Aug 28, 2026, 14:20Alyson Reidy: Factor Man and Community Support Take Center Stage at NBDF 2026
-
Aug 28, 2026, 14:09New Study Highlights Pregnancy Challenges in Inherited Bleeding Disorders – Glanzmann’s Research Foundation
-
Aug 28, 2026, 13:55Swatee C: A Guide to Common Uterine Disorders
-
Aug 28, 2026, 12:14Gathoni Kungu: Run to End Postpartum Hemorrhage and Save Lives